Guardant Health, Inc. (GH): Depreciation & Amortization
$39.74M
Year ended 2025-12-31
$38.46M
Trailing 12 months to 2026-06-30
+3.4%
3-year compound annual growth
+19.9%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $39.74M | -6.3% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $42.39M | -1.2% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $42.88M | +19.2% | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | $35.96M | +61.5% | 2025-02-20, From 2022-01-01 |
| 2021-12-31 | $22.27M | +38.6% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $16.07M | +40.8% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $11.41M | +59.9% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $7.14M | +37.1% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $5.21M | +41.0% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $3.69M | n/a | 2019-03-19, From 2016-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Guardant Health, Inc. (GH) | 2025-12-31 | $39.74M | -6.3% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $22.61M | -53.8% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $21.41M | -8.7% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $136.10M | +8.6% |
| Natera, Inc. (NTRA) | 2025-12-31 | $41.76M | +34.9% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $15.02M | +5.8% |
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $78.00M | -10.2% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $40.77M | +154.9% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $24.12M | -3.2% |
Compare GH, CAI, VCYT, RDNT side by side · Screen every company in Services-Medical Laboratories ↗